The Bath search engine revolutionising drug discovery

A four-talk collaboration between BRLSI and the University of Bath to explore how new research and innovative products can impact and improve the lives of people around the world. 

We want everyone to be able to enjoy & learn from this series of four talks – so please choose a free ticket, or if you’re happy to pay £3 for a ticket we are very grateful for your contribution towards our talks programme, collections care and educational activities. To get a single purchase ticket for the whole series, choose a Series Pass (available until the first talk on 10 September).

Join David Kelly, University of Bath alumnus and local CEO and Dr Andrew Chalmers, University researcher as they discuss their journey in founding CiteAb, an antibody search engine which helps 800,000 researchers each year with their work into new drug development. This panel discussion will shed light on academic and industry collaboration, explore the future of innovation and enterprise in Bath and what defines a successful business in this vibrant city.

University of Bath alumnus David Kelly is the founder and CEO of Storm Consultancy. He is a well-known figure in the Bristol and Bath tech startup / scaleup community. He is one of the founders of Bath Digital Festival, is chair of the TechSPARK community board in Bath, is a mentor and advisor to the University of Bath Enterprise team and chairs the Co-forest initiative.

Dr Andrew Chalmers is the CEO of CiteAb and a visiting lecturer at the University of Bath. He conceived the idea of a citation-based antibody search engine, co-founded CiteAb and now leads the company on its mission to help scientists and suppliers by collecting reagent citation data.